NSEMonitoring Agency Report6d ago · 13 Aug 2026, 06:20 pm
Monitoring Agency Report
Pavna Industries Limited · PAVNAIND
✦ AI SummaryFundraise
Pavna Industries Limited has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026, related to the Preferential Issue of Equity Shares and Fully Convertible Warrants. The report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Monitoring Agency Report for the quarter ended June 30, 2026
Attachments (1)
📄pdf
Download →
PAVNA_13082026182021_MAR30062026rsdsd.pdf
View document text
PAVNA INDUSTRIES LIMITED
CIN-L34109UP1994PLC016359
Registered Office: Vimlanchal, Hari Nagar, Aligarh, Uttar Pradesh – 202001
Corporate Address: Sushayat Khurd Aligarh-Agra Road, Near Mangalayatan Mandir,
Sasni, Hathras, Aligarh, Uttar Pradesh, India, 204216
Email: cs@pavnagroup.com; Website: www.pavna.in Tel No.: +91-8006409332
August 13, 2026
To, To,
The BSE Limited The National Stock Exchange of India
Dept of Corporate Services Limited
Phirozee Jeejeebhoy Towers, The Listing Department
Dalal Street, Fort, Exchange Plaza, C-1, Block G, Bandra Kurla
Mumbai - 400001 (Maharashtra) Complex, Bandra (East),
Scrip Code :543915 Mumbai- 400051(Maharashtra)
Symbol :PAVNAIND
ISIN-INE07S101038
Sub: Monitoring Agency Report for the quarter ended June 30, 2026.
Ref: Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended from time to time (“Listing
Regulations”).
Dear Sir/Mam,
Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended from time to time (“Listing
Regulations”) read with Regulation 162A of SEBI (Issue of Capital and Disclosure Requirements)
Regulations, 2018 ,we are enclosing herewith the Monitoring Agency Report dated August 13,
2026 for the quarter ended June 30, 2026, in relation to the Preferential Issue of Equity Shares
and Fully Convertible Warrants of the Company has received from Monitoring Agency, Care
Ratings Limited as per Monitoring Agency Agreement dated October 4, 2024.
You are requested to take the above information on record.
Yours faithfully
For Pavna Industries Limited
Swapnil Jain
Managing Director
DIN-01542555
Encl: As above
No. CARE/KRO/GEN/2026-27/1067
The Board of Directors
Pavna Industries Limited
Vimlachal Hari Nagar Aligarh
Uttar Pradesh, India
Pin- 202001
August 13, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Preferential Issue of Equity Share
and Fully Convertible Warrants of Pavna Industries Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Preferential issue of equity shares and fully convertible warrants
for the amount aggregating to Rs. 210.70 crore of the Company and refer to our duties cast under 162A of the Securities
& Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid
SEBI Regulations and Monitoring Agency Agreement dated October 04, 2024.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Abhishek Khemka
Associate Director
Abhishek.Khemka@careedge.in
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
Report of the Monitoring Agency
Name of the issuer: Pavna Industries Ltd
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: Refer Section 3
(b) Range of Deviation: Refer Section 3
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects
of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA
which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and
opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner
whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship
between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not
act as an expert as defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that
there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue
proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting
their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been
reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Abhishek Khemka
Designation of Authorized person/Signing Authority: Associate Director
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
1) Issuer Details:
Name of the issuer : Pavna Industries Limited
Name of the promoter : Mr. Swapnil Jain & Mrs. Asha Jain
Industry/sector to which it belongs : Manufacturing (Auto Ancillary)
2) Issue Details
Issue Period : Jan 29, 2025
Type of issue (public/rights) : Preferential Issue
Type of specified securities : Equity shares and Fully Convertible warrants
IPO Grading, if any : Not Applicable
Issue size (in crore) : Rs. 210.70 crore
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital Road,
15 Park Street, Kolkata – 700016 Off Eastern Express Highway, Sion (East), Mumbai
Phone: +91-33-4018 1600/2283 1803 - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information
/ certifications Comments of the Comments of the
Particulars Reply considered by
Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
CA certificate*, Bank The utilization of the fund is according to
Whether all utilization is as per the
Yes statements, Management the objectives mentioned as per Board No comments
disclosures in the Offer Document?
certificate Resolution dated January 29, 2025.
Whether shareholder approval has been
obtained in case of material Not CA certificate and
Nil No comments
deviations# from expenditures applicable Management certificate
disclosed in the Offer Document?
Whether the means of finance for the
CA Certificate and
disclosed objects of the issue have No Nil No comments
Management Certificate
changed?
Is there any major deviation observed
As per last MA report
over the earlier monitoring agency No Nil No comments
(Q4FY26)
reports?
Whether all Government/statutory Not
CA Certificate and
approvals related to the object(s) have Nil No comments
Management Certificate
been obtained? Appliable
Whether all arrangements pertaining to Not
CA Certificate and
technical assistance/collaboration are in Nil No comments
Management Certificate
operation? Appliable
CARE Ratings Limited
Unit N
[Showing first 8,000 characters — download PDF for full document]